Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, by Therapy
1.4.2 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, by Therapeutics Class
1.4.3 Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy
3.1 Asia Pacific Mono Drug Therapy Market by Country
3.2 Asia Pacific Combination Drug Therapy Market by Country
Chapter 4. Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
4.1 Asia Pacific Alpha Blockers Market by Country
4.2 Asia Pacific 5- alpha Reductase Inhibitors Market by Country
4.3 Asia Pacific Phosphodiesterase-5 Inhibitors Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Country
5.1 China Benign Prostatic Hyperplasia Therapeutics Market
5.1.1 China Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.1.2 China Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.2 Japan Benign Prostatic Hyperplasia Therapeutics Market
5.2.1 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.2.2 Japan Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.3 India Benign Prostatic Hyperplasia Therapeutics Market
5.3.1 India Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.3.2 India Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.4 South Korea Benign Prostatic Hyperplasia Therapeutics Market
5.4.1 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.4.2 South Korea Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.5 Singapore Benign Prostatic Hyperplasia Therapeutics Market
5.5.1 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.5.2 Singapore Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.6 Malaysia Benign Prostatic Hyperplasia Therapeutics Market
5.6.1 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.6.2 Malaysia Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
5.7 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market
5.7.1 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapy
5.7.2 Rest of Asia Pacific Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class
Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Astellas Pharma, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.3 Eli Lilly and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expense
6.4 Allergan PLC (AbbVie)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.5 Merck Group (Merck Sharp & Dohme Corp.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Boehringer Ingelheim International Gmbh
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional & Segmental Analysis
6.6.4 Research & Development Expenses
6.7 Teva Pharmaceutical Industries Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Sanofi S.A.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Abbott Laboratories
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense
Unique Offerings 